Healthcare Triangle, Inc (HCTI) Fair Value & Analysis
Healthcare · US · Market cap $4.4M
Healthcare Triangle, Inc
HCTI · US
Fair value as of: Jul 16, 2026
From 1 valuation models · updated yesterday
Share price −17.8% over the past month.
Price vs Fair Value (12 months)
12‑month range $1.70 – $1,031 · fair‑value band $0.1105 – $0.2040 · the $1.89 price screens above the $0.1700 fair value. As of Jul 16, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Healthcare Triangle, Inc (HCTI) currently trades at $1.89, while our model-based Fair Value estimate is $0.1700, implying the stock looks roughly 91.0% overvalued today. We read business quality at 16/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Over the trailing twelve months, Healthcare Triangle, Inc generated revenue of $20.0M at a net margin of -69.7%. Revenue grew 166.1% year over year. It earns a return on equity of -45.6%. Net debt stands at $3.1M. Fundamentals as of Jul 16, 2026
Our scenario range runs from $0.1105 (bear case) to $0.2040 (bull case); at $1.89, the current price sits above that range. For context, the median of 10 Healthcare peers we cover trades at -37% fair-value upside, at -91%, HCTI screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 16, 2026. TTM = trailing twelve months.
About the company
Healthcare Triangle, Inc., a healthcare information technology company, focuses on advancing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sciences industry. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation. The company's software platforms include CloudEz, an enterprise multi-cloud transformation and management platform that enables customers to manage their cloud infrastructure in private, hybrid, and public cloud infrastructures; DataEz, a cloud-based data analytics and data science platform for the data analytics and data science requirements of life sciences/pharmaceutical and healthcare …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Healthcare Triangle, Inc reported revenue of $13.9M in FY2025 versus $35.3M in FY2021, a compound −20.8%/yr. Reported net income was −$9.5M in FY2025.
Is HCTI fairly valued? → Check now
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $172.61 | $104.16 | -40% |
| Pro Medicus Limited PME | A$172.80 | A$32.25 | -81% |
| BrightSpring Health Services, Inc BTSG | $57.40 | $23.87 | -58% |
| Tempus AI, Inc TEM | $48.61 | $12.67 | -74% |
| HealthEquity, Inc HQY | $86.03 | $54.47 | -37% |
| Hinge Health, Inc HNGE | $68.85 | $78.43 | +14% |
| M3, Inc MTHRY | $5.03 | $7.44 | +48% |
| 10x Genomics, Inc TXG | $32.94 | $22.67 | -31% |
| Waystar Holding WAY | $18.41 | $12.86 | -30% |
| Ping An Healthcare and Technology Company PANHF | $0.9000 | $0.5700 | -37% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Healthcare Triangle, Inc (HCTI) undervalued?
What is the fair value of HCTI?
What is the quality score of HCTI?
What is the revenue of Healthcare Triangle, Inc (HCTI)?
What is the net profit margin of HCTI?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Healthcare Triangle, Inc analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.